ICU Medical (NASDAQ:ICUI) Shares Break Above 200 Day Moving Average – Should You Sell?

Shares of ICU Medical, Inc. (NASDAQ:ICUI) passed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $146.40 and traded as high as $166.71. ICU Medical shares last traded at $164.03, with a volume of 290,623 shares trading hands.

Analyst Upgrades and Downgrades

Several research firms have recently commented on ICUI. Raymond James Financial reaffirmed a “strong-buy” rating and issued a $200.00 target price on shares of ICU Medical in a research report on Friday, August 7th. Zacks Research downgraded ICU Medical from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 28th. Wall Street Zen raised ICU Medical from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 8th. BTIG Research increased their price objective on ICU Medical from $170.00 to $200.00 and gave the stock a “buy” rating in a research report on Friday, August 7th. Finally, Weiss Ratings raised ICU Medical from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $192.80.

ICU Medical Stock Performance

The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.21 and a current ratio of 2.43. The company has a market cap of $4.00 billion, a price-to-earnings ratio of 135.90, a P/E/G ratio of 2.06 and a beta of 0.75. The company has a fifty day moving average of $168.96 and a two-hundred day moving average of $146.61.

ICU Medical (NASDAQ:ICUI) last announced its earnings results on Thursday, August 6th. The medical instruments supplier reported $2.37 EPS for the quarter, beating the consensus estimate of $1.91 by $0.46. ICU Medical had a return on equity of 7.91% and a net margin of 1.39%.The business had revenue of $547.88 million for the quarter, compared to analysts’ expectations of $533.44 million. During the same period in the prior year, the business posted $2.10 earnings per share. The firm’s revenue was up .5% on a year-over-year basis. ICU Medical has set its FY 2026 guidance at 8.600-9.000 EPS. Equities research analysts anticipate that ICU Medical, Inc. will post 7.22 EPS for the current year.

Insider Activity at ICU Medical

In related news, Director Elisha Finney sold 378 shares of the stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $182.48, for a total transaction of $68,977.44. Following the transaction, the director directly owned 4,871 shares of the company’s stock, valued at $888,860.08. This represents a 7.20% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Virginia Sanzone sold 4,856 shares of the firm’s stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $168.69, for a total transaction of $819,158.64. Following the completion of the sale, the vice president owned 14,604 shares of the company’s stock, valued at $2,463,548.76. The trade was a 24.95% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 21,830 shares of company stock worth $3,905,003. Corporate insiders own 2.10% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in ICUI. Allworth Financial LP acquired a new stake in ICU Medical in the second quarter valued at approximately $26,000. Hilton Head Capital Partners LLC bought a new position in shares of ICU Medical in the 4th quarter worth $32,000. Public Employees Retirement System of Ohio bought a new position in shares of ICU Medical in the 2nd quarter worth $51,000. Rockefeller Capital Management L.P. grew its position in ICU Medical by 21.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 823 shares of the medical instruments supplier’s stock valued at $117,000 after purchasing an additional 146 shares during the period. Finally, Kemnay Advisory Services Inc. acquired a new stake in ICU Medical in the 4th quarter valued at $120,000. 96.10% of the stock is owned by institutional investors and hedge funds.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures and sells medical devices used in infusion therapy, critical care and oncology. Its product portfolio includes infusion pumps, IV administration sets, needle-free connectors, vascular access devices, patient monitoring equipment and related accessories designed to support the delivery of fluids and medications and the monitoring of patients in healthcare settings.

The company also provides products for the safe handling of hazardous drugs, including closed-system transfer devices used in oncology and pharmacy operations.